Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

7.26
Delayed Data
As of 3:58pm ET
 +0.05 / +0.69%
Today’s Change
3.96
Today|||52-Week Range
11.40
+49.38%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close7.21
Today’s open7.20
Day’s range7.19 - 7.54
Volume9,202
Average volume (3 months)17,336
Market cap$22.0M
Dividend yield--
Data as of 3:58pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)-250.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+26.46%
P/E ratio31.4
Price/Sales1.94
Price/Book2.36

Competitors

 Today’s
change
Today’s
% change
--Cell Source Inc0.000.00%
NSPHNanosphere Inc+0.02+0.76%
CANFCan Fite Biopharma L...+0.06+3.51%
RXIIRxi Pharmaceuticals ...+0.01+1.52%
Data as of 4:00pm ET, 08/31/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$7.6M
Annual profit (last year)-$167.2K
Net profit margin-2.20%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, CFO, Secretary &
Treasurer
Michael F. Brigham
Director, Chief Scientific Officer &
VP
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts

Partner Offers